Nektar Therapeutics

News
nektar_sign-san_francisco

Nektar and PureTech merger talks called off

Just days after revealing that it was in discussions with Nektar Therapeutics over a possible merger, PureTech Health has said the negotiations have been terminated by mutual agreement.

News
nektar_sign-san_francisco

After bempeg failure, Nektar wields the axe

Nektar has said it will cut 70% of its workforce in the wake of the comprehensive failure in trials of its immuno-oncology candidate bempegaldesleukin, which was discontinued last week.